Search

Your search keyword '"Kobayashi, Masayoshi"' showing total 412 results

Search Constraints

Start Over You searched for: Author "Kobayashi, Masayoshi" Remove constraint Author: "Kobayashi, Masayoshi" Database Unpaywall Remove constraint Database: Unpaywall
412 results on '"Kobayashi, Masayoshi"'

Search Results

1. Pulmonary function and chest CT abnormalities 3 months after discharge from COVID-19, 2020–2021: A nation-wide multicenter prospective cohort study from the Japanese respiratory society

2. Effect of individualized occupational therapy on cognition among patients with schizophrenia: A randomized controlled trial

7. Impairment of Social-Related Quality of Life in COVID-19 Pneumonia Survivors: A Prospective Longitudinal Study

9. A comparison of the incidence of ≥ grade 2 radiation pneumonitis between intensity-modulated radiotherapy and three-dimensional conformal radiotherapy in patients with unresectable non-small cell lung cancer treated with durvalumab after concurrent chemoradiotherapy

11. Long-term impairment of social-related quality of life in COVID-19 pneumonia survivors: a prospective longitudinal study

13. Efficacy of tokishakuyakusan and mecobalamin on post-infectious olfactory dysfunction: A prospective multicenter study

15. Outcomes of an interdisciplinary return to work intervention including occupational therapy for mood and adjustment disorders: A single-arm clinical trial

27. Transplantation of Human Induced Pluripotent Stem Cell-Derived Airway Cells on Vitrigel Membrane into Rat Nasal Cavity

28. Lipocalin 15 in the olfactory mucus is a biomarker for Bowman’s gland activity

30. COVID-19-associated leukoencephalopathy in the absence of severe hypoxia with subsequent improvement: a case report

33. International consensus statement on allergy and rhinology: Olfaction

38. MPC-8 Serum anti-zinc finger FYVE domain-containing protein 21 (ZFYVE21) autoantibody as a novel biomarker for oligodendroglioma IDH-mutant and 1p/19q co-deletion

43. Non-inferior clinical outcomes of immune checkpoint inhibitors in non-small cell lung cancer patients with interstitial lung disease

45. A Phase II, Multicenter, Randomized, Placebo-Controlled Study of Benralizumab, a Humanized Anti-IL-5R Alpha Monoclonal Antibody, in Patients With Eosinophilic Chronic Rhinosinusitis

50. Sinonasal Undifferentiated Carcinoma

Catalog

Books, media, physical & digital resources